Gassert Chad's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed May 3, 2024
- Accession no.
- 0001871002-24-000010
- Filed
- May 3, 2024
- Trade date
- May 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.33M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gassert ChadCIK 0001871002 | Officer (SVP - CORP. DEV. & STRATEGY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | Common Stock | SSaleDisposed | −20,000 | $66.62 | −$1,332,400 | 233,226 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.